Some plans cover Zepbound for eligible patients, while others require prior authorization or exclude obesity medications
Medicare Change: As of 2026, many manufacturer programs have restricted access for Medicare Part D beneficiaries, though these patients may now qualify for the new $50 monthly copay cap through federal programs
Medication may be bundled into that price or billed separately, so the important questions are what the recurring charge includes, what happens at refill, and whether the program has a separate pharmacy or shipping bill
This offering is part of Omadas broader cardiometabolic strategy, which includes Omada for Cholesterol and the launch of prescribing capabilities starting with GLP-1s and other obesity medications, so employers can choose the pathways that best fit their benefit design
Circu, M.L
If you have a history of any or a combination of these health problems, it would be beneficial to discuss which would be best for you with a healthcare professional